ArticleJournal of medical case reports2025
Renal cell carcinoma accompanied by aldosterone-secreting contralateral adrenal metastasis: a case report.
Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundKidney cancer is a highly prevalent malignancy, consistently ranking among the top ten cancers affecting both men and women, and its mortality has been increasing globally. Renal cell carcinoma is the most common type and has a tendency to metastasize, with a predilection for spreading to other organs. While the adrenal gland is located adjacent to the kidney, metastasis of renal cell carcinoma to the adrenal gland is considered rare compared with other sites such as the lungs, liver, and bones. In addition, the occurrence of metastasis to the contralateral adrenal gland is an exceedingly rare phenomenon. CASE PRESENTATION: A 57-year-old Arabic female patient presented with intermittent hematuria over a period of several months. The patient's medical and surgical history revealed no significant findings. Laboratory tests revealed normal results, with the exception of elevated aldosterone levels and a high aldosterone renin ratio, despite a normal blood pressure reading. Further investigations revealed the coexistence of renal cell carcinoma and adrenal adenoma on the left side, along with adrenal mass on the right side, which confirmed its metastatic nature after resection and pathological study. As a result, a left nephrectomy and right adrenalectomy were subsequently conducted. Postsurgery, the aldosterone level normalized, confirming the secretory function of the metastasized renal carcinoma in the right adrenal gland.
conclusionThe secretion of aldosterone from an adrenal metastasis arising from renal cell carcinoma is a rare phenomenon that healthcare providers should bear in mind during differential diagnosis. It is imperative to conduct thorough investigations and extended research to understand the potential complications associated with this unique presentation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.